1. Home
  2. KROS vs SBC Comparison

KROS vs SBC Comparison

Compare KROS & SBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • SBC
  • Stock Information
  • Founded
  • KROS 2015
  • SBC 2000
  • Country
  • KROS United States
  • SBC United States
  • Employees
  • KROS N/A
  • SBC N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • SBC
  • Sector
  • KROS Health Care
  • SBC
  • Exchange
  • KROS Nasdaq
  • SBC NYSE
  • Market Cap
  • KROS 558.9M
  • SBC 463.1M
  • IPO Year
  • KROS 2020
  • SBC N/A
  • Fundamental
  • Price
  • KROS $14.53
  • SBC $5.10
  • Analyst Decision
  • KROS Buy
  • SBC
  • Analyst Count
  • KROS 13
  • SBC 0
  • Target Price
  • KROS $20.63
  • SBC N/A
  • AVG Volume (30 Days)
  • KROS 477.3K
  • SBC 158.2K
  • Earning Date
  • KROS 08-06-2025
  • SBC 08-23-2025
  • Dividend Yield
  • KROS N/A
  • SBC N/A
  • EPS Growth
  • KROS N/A
  • SBC N/A
  • EPS
  • KROS 0.11
  • SBC 0.50
  • Revenue
  • KROS $214,713,000.00
  • SBC $197,936,201.00
  • Revenue This Year
  • KROS $5,006.76
  • SBC N/A
  • Revenue Next Year
  • KROS N/A
  • SBC $12.95
  • P/E Ratio
  • KROS $132.80
  • SBC $10.03
  • Revenue Growth
  • KROS 91657.70
  • SBC N/A
  • 52 Week Low
  • KROS $9.12
  • SBC $2.62
  • 52 Week High
  • KROS $72.37
  • SBC $12.50
  • Technical
  • Relative Strength Index (RSI)
  • KROS 64.67
  • SBC N/A
  • Support Level
  • KROS $13.26
  • SBC N/A
  • Resistance Level
  • KROS $14.68
  • SBC N/A
  • Average True Range (ATR)
  • KROS 0.41
  • SBC 0.00
  • MACD
  • KROS 0.12
  • SBC 0.00
  • Stochastic Oscillator
  • KROS 89.35
  • SBC 0.00

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About SBC SBC MEDICAL GROUP HOLDINGS INCRPRTD

SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). Company provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.

Share on Social Networks: